- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05423366
Comparative Effects of Focused and Unfocused (Radial) ESWT in the Treatment of Patellar Tendinopathy.
September 27, 2022 updated by: Volkan Şah, Yuzuncu Yıl University
Comparative Effects of Large Focused and Controlled Unfocused (Radial) Extracorporeal Shock Wave Therapies in the Treatment of Patellar Tendinopathy.
There is no scientific study in the literature regarding the use of different extracorporeal shock wave therapies (ESWT) in the treatment of patellar tendinopathy.
In this study, we aim to investigate both the effectiveness of ESWT and which type of ESWT can be more effective in the treatment of patellar tendinopathy.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Van, Turkey
- Yuzuncu Yil University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Engaging in active sports, being 18 years or older, history of activity-related knee pain in the patellar tendon or patellar insertion, symptoms lasting longer than 8 weeks (non-acute), VISA-P score less than 80 before treatment, pain during knee loading on tendon or tendon it remains isolated in the limited part of the bone junction and does not spread to the entire patellar region (to differentiate patellar tendinopathy and patellofemoral pain).
Exclusion Criteria:
- Being under the age of 18, acute knee or acute patellar tendon injury, chronic inflammatory joint diseases (rheumatoid arthritis, etc.), using immunosuppressive or corticosteroid medication in the last 6 months, previous knee surgery (in the anterior cruciate ligament or patellar tendon), knee in the last 1 month local (corticosteroid) injection, contraindications for ESWT treatment (eg pregnancy, malignancy, coagulopathy), previous ESWT treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Large-Focused Extracorporeal Shock Wave Therapy
|
The ESWT device is product of Elettronica Pagani, Italy.
|
|
Active Comparator: Controlled-Unfocused (Radial) Extracorporeal Shock Wave Therapy
|
The ESWT device is product of Elettronica Pagani, Italy.
|
|
Sham Comparator: Sham Extracorporeal Shock Wave Therapy
|
The ESWT device is product of Elettronica Pagani, Italy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale (VAS)
Time Frame: at baseline.
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
at baseline.
|
|
Visual Analogue Scale (VAS)
Time Frame: 3 weeks after baseline.
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
3 weeks after baseline.
|
|
Visual Analogue Scale (VAS)
Time Frame: 7 weeks after baseline.
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
7 weeks after baseline.
|
|
Visual Analogue Scale (VAS)
Time Frame: 15 weeks after baseline.
|
patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse
|
15 weeks after baseline.
|
|
Victorian Institute of Sports Assessment-Patella (VISA-P)
Time Frame: at baseline.
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire.
Scores below 80 are usually indicative of patellar tendinopathy.
|
at baseline.
|
|
Victorian Institute of Sports Assessment-Patella (VISA-P)
Time Frame: 3 weeks after baseline.
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire.
Scores below 80 are usually indicative of patellar tendinopathy.
|
3 weeks after baseline.
|
|
Victorian Institute of Sports Assessment-Patella (VISA-P)
Time Frame: 7 weeks after baseline.
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire.
Scores below 80 are usually indicative of patellar tendinopathy.
|
7 weeks after baseline.
|
|
Victorian Institute of Sports Assessment-Patella (VISA-P)
Time Frame: 15 weeks after baseline.
|
The Victorian Institute of Sport Assessment-Patella (VISA-P) is a questionnaire to assess the severity of patellar tendinopathies.
Theoretically, a maximum score of 100 and a minimum score of 0 can be obtained in the VISA-P questionnaire.
Scores below 80 are usually indicative of patellar tendinopathy.
|
15 weeks after baseline.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 16, 2022
Primary Completion (Anticipated)
November 28, 2022
Study Completion (Anticipated)
December 19, 2022
Study Registration Dates
First Submitted
June 14, 2022
First Submitted That Met QC Criteria
June 14, 2022
First Posted (Actual)
June 21, 2022
Study Record Updates
Last Update Posted (Actual)
September 28, 2022
Last Update Submitted That Met QC Criteria
September 27, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- University of Van YüzüncüYıl
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patellar Tendinitis
-
Linnaeus UniversityCompletedPatellar TendinitisSweden
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingShock Wave Threapy for Patellar TendinitisChina
-
University of AlcalaActive, not recruitingPatellar TendinitisSpain
-
Universidad de ZaragozaCompletedPatellar Tendinitis | Patella; Tendinitis | Patellar Tendinopathy / Jumpers KneeSpain
-
North Dakota State UniversityCompletedPatellar TendinitisUnited States
-
Istituto Ortopedico RizzoliCompletedTendinopathy | Patellar Tendinopathy | Patellar TendinitisItaly
-
University of DelawareCompletedJumper's Knee | Patellar Tendinopathy | Patellar Tendinitis | Patellar Tendon Pain | Patellar TendinosisUnited States
-
University Hospital, MontpellierNot yet recruitingIdentification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk (TENVOL)Knee Injuries | Jumper's Knee | Patellar Tendinitis | Musculoskeletal InjuriesFrance
-
Cardenal Herrera UniversityCompletedPatellar TendinitisSpain
-
University of Wisconsin, MadisonGeneral ElectricCompleted
Clinical Trials on Extracorporeal Shock Wave Therapy (ESWT)
-
Yuzuncu Yıl UniversityCompletedHip OsteoarthritisTurkey
-
Storz Medical AGTerminatedErectile DysfunctionGermany
-
Oslo University HospitalUnknownShoulder Impingement Syndrome | Subacromial Shoulder PainNorway
-
Istanbul UniversityIstanbul University - Cerrahpasa (IUC)Not yet recruitingCalcinosis Cutis | Scleroderma
-
Okan UniversityMedipol UniversityCompletedDiabetes Mellitus | Frozen ShoulderTurkey
-
National Taiwan University HospitalRecruitingStroke | Muscle SpasticityTaiwan
-
National Taiwan University HospitalRecruitingStroke | Spasticity, MuscleTaiwan
-
The University of Hong KongRecruiting
-
Medical University of SilesiaUnknownPatellofemoral Pain Syndrome | Knee Pain ChronicPoland
-
Kaohsiung Medical University Chung-Ho Memorial...Completed